Hester Biosciences to Divest 43.81% Stake in Subsidiary Texas Lifesciences

Hester Biosciences Ltd. announced the divestment of 43.81% equity stake in its subsidiary, Texas Lifesciences Private Limited (TLPL), to the existing promoter shareholders of TLPL. The decision was made at the Board Meeting held on 11 March 2026. TLPL is not a material subsidiary of the company and will cease to be a subsidiary upon completion of the share transfer transaction. The transfer of shares is expected to be completed within three months from the date of the agreement, with a total aggregate value of INR 92 million. Hester will continue to do business with TLPL promoter group and maintain an 11% equity stake in the company.